7:168–72.34 34 Pellock JM. Safety of Diastat, a rectal gel formulation of diazepam for acute seizure treatment. Drug Saf. 2004; 27:383–92.
35 35 O’Regan ME, Brown JK, Clarke M. Nasal rather than rectal benzodiazepines in the management of acute childhood seizures? Dev Med Child Neurol. 1996; 38:1037–45.
36 36 Mahmoudian T, Zadeh MM. Comparison of intranasal midazolam with intravenous diazepam for treating acute seizures in children. Epilepsy Behav. 2004; 5:253–5.
37 37 Holsti M, Sill BL, Firth SD, Filloux FM, Joyce SM, Furnival RA. Prehospital intranasal midazolam for the treatment of pediatric seizures. Pediatr Emerg Care. 2007; 23:148–53.
38 38 McIntyre J, Robertson S, Norris E, et al. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. Lancet 2005; 366:205–10.
39 39 Baysun S, Aydin OF, Atmaca E, Gürer YK. A comparison of buccal midazolam and rectal diazepam for the acute treatment of seizures. Clin Pediatr (Phila). 2005; 44:771–6.
40 40 Wiznitzer M. Buccal midazolam for seizures. Lancet. 2005; 366: 182–3.
41 41 Wiznitzer M. Buccal midazolam is effective for acute treatment of seizures. J Pediatr. 2006; 148:143.
42 42 Towne AR, DeLorenzo RJ. Use of intramuscular midazolam for status epilepticus. J Emerg Med. 1999; 17:323–8.
43 43 Warden CR, Frederick C. Midazolam and diazepam for pediatric seizures in the prehospital setting. Prehosp Emerg Care. 2006; 10:463–7.
44 44 Chamberlain JM, Altieri MA, Futterman C, Young GM, Ochsenschlager DW, Waisman Y. A prospective, randomized study comparing intramuscular midazolam with intravenous diazepam for the treatment of seizures in children. Pediatr Emerg Care. 1997; 13:92–4.
45 45 Silbergleit R, Durkalski V, Lowenstein D, et al. Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med. 2012; 366:591–600.
46 46 Vilke GM, Sharieff GQ, Marino A, Gerhart AE, Chan TC. Midazolam for the treatment of out‐of‐hospital pediatric seizures. Prehosp Emerg Care. 2002; 6:215–17.
47 47 Ribacoba‐Montero R, Salas‐Puig J. Simultaneous bilateral fractures of the hip following a grand mal seizure. An unusual complication. Seizure. 1997; 6:403–4.
48 48 Torreggiani WC, Lyburn ID, Harris AC, Nicolaou S. Odontoid fracture following an epileptic seizure. Australas Radiol. 2001; 45:359–61.
49 49 McArthur CL III, Rooke CT. Are spinal precautions necessary in all seizure patients? Am J Emerg Med. 1995; 13:512–13.
50 50 Gnanalingham K, Macanovic M, Joshi S, Afshar F, Yeh J. Non‐traumatic compression fractures of the thoracic spine following a seizure –treatment by percutaneous kyphoplasty. Minim Invasive Neurosurg. 2004; 47:256–7.
51 51 Kruitbosch JM, Schouten EJ, Tan IY, Veendrick‐Meekes MJ, de Vocht JW. Cervical spinal cord injuries in patients with refractory epilepsy. Seizure. 2006; 15:633–6.
52 52 Zwimpfer TJ, Brown J, Sullivan I, Moulton RJ. Head injuries due to falls caused by seizures: a group at high risk for traumatic intracranial hematomas. J Neurosurg. 1997; 86:433–7.
53 53 Walls RM, Sagarin MJ. Status epilepticus. N Engl J Med. 1998; 339:409.
54 54 Verma A, Bedlack RS, Radtke RA, VanLandingham KE, Erwin CW. Succinylcholine induced hyperkalemia and cardiac arrest death related to an EEG study. J Clin Neurophysiol. 1999; 16:46–50.
55 55 Lowenstein DH, Alldredge B. Managing status epilepticus. Lancet 1990; 336:1451.
56 56 Lowenstein DH. The management of refractory status epilepticus: an update. Epilepsia. 2006; 47 (Suppl 1):35–40.
57 57 Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America’s Working Group on Status Epilepticus. JAMA. 1993; 270:854–9.
58 58 ACEP Clinical Policies Committee, Clinical Policies Subcommittee on Seizures. Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with seizures. Ann Emerg Med. 2004; 43:605–25.
59 59 Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012; 17:3–23.
60 60 Kapur J, Elm J, Chamberlain JM, et al. Randomized trial of three anticonvulsant medications for status epilepticus. N Engl J Med. 2019; 381:2103–13.
61 61 Aggarwal P, Wali JP. Lidocaine in refractory status epilepticus: a forgotten drug in the emergency department. Am J Emerg Med. 1993; 1 1:243–4.
62 62 Pascual J, Sedano MJ, Polo JM, Berciano J. Intravenous lidocaine for status epilepticus. Epilepsia. 1988; 29:584–9.
63 63 Hamano S, Sugiyama N, Yamashita S, et al. Intravenous lidocaine for status epilepticus during childhood. Dev Med Child Neurol. 2006; 48:220–2.
64 64 Walker IA, Slovis CM. Lidocaine in the treatment of status epilepticus. Acad Emerg Med. 1997; 4:918–22.
65 65 Yeoman P, Hutchinson A, Byrne A, Smith J, Durham S. Etomidate infusions for the control of refractory status epilepticus. Intensive Care Med. 1989; 15:255–9.
66 66 Sheth RD, Gidal BE. Refractory status epilepticus: response to ketamine. Neurology. 1998; 51:1765–6.
67 67 Nathan BR, Smith TL, Bleck T. The use of ketamine in the treatment of refractory status epilepticus (abstract). Neurology. 2002; 58 (Suppl 3):A197.
68 68 Fountain NB, Adams RE. Midazolam treatment of acute and refractory status epilepticus. Clin Neuropharmacol. 1999; 22: 261–7.
69 69 Prasad A, Worrall BB, Bertram EH, Bleck TP. Propofol and midazolam in the treatment of refractory status epilepticus. Epilepsia. 2001; 42:380–6.
70 70 Stecker MM, Kramer TH, Raps EC, O’Meeghan R, Dulaney E, Skaar DJ. Treatment of refractory status epilepticus with propofol: clinical and pharmacokinetic findings. Epilepsia. 1998; 39:18–26.
71 71 Rossetti AO, Reichhart MD, Schaller MD, Despland PA, Bogousslavsky J. Propofol treatment of refractory status epilepticus: a study of 31 episodes. Epilepsia. 2004; 45:757–63.
72 72 Schor NF, Riviello JJ Jr. Treatment with propofol: the new status quo for status epilepticus? Neurology. 2005; 65:506–7.
73 73 Parviainen I, Uusaro A, Kälviäinen R, Mervaala E, Ruokonen E. Propofol in the treatment of refractory status epilepticus. Intensive Care Med. 2006; 32:1075–9.
74 74 Rossetti AO, Bromfield EB. Efficacy of rapid IV administration of valproic acid for status epilepticus. Neurology. 2005; 65: 500–1.
75 75 Wheless JW, Vazquez BR, Kanner AM, Ramsay RE, Morton L, Pellock JM. Rapid infusion with valproate sodium is well tolerated in patients with epilepsy. Neurology. 2004; 63:1507–8.
76 76 Peters CN, Pohlmann‐Eden B. Intravenous valproate as an innovative therapy in seizure emergency situations including status epilepticus–experience in 102 adult patients. Seizure. 2005; 14:164–9.
77 77 Fernandez IS, Abend NS, Agadi S, et al. Time from convulsive status epilepticus onset to anticonvulsant
